Stephen Huo

Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States

Daniel M. Geynisman, Edward Broughton, Yi Hao et al. · Urologic Oncology Seminars and Original Investigations · 2021 · 42 citations · Full text

Medicine, Oncology, Urology +17

The Impact of Outpatient versus Inpatient Administration of CAR-T Therapies on Clinical, Economic, and Humanistic Outcomes in Patients with Hematological Cancer: A Systematic Literature Review

Doris K. Hansen, Yi-Hsuan Liu, Sandip Ranjan et al. · Cancers · 2023 · 31 citations · Full text

Medicine, Hematology, Oncology +16

Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma

Bradley A. McGregor, Daniel M. Geynisman, Mauricio Burotto et al. · The Oncologist · 2022 · 11 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma

Bradley A. McGregor, Daniel M. Geynisman, Mauricio Burotto et al. · European Urology Oncology · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +13